VOLITIONRX LTD (VNRX) Stock Income Statement
NYSEARCA:VNRX - NYSE Arca - US9286611077 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.31M | 1.23M | 775.30K | 310.00K | 90.00K | |||
| Minority Interest Expense | 238.50K | 290.20K | 358.00K | 330.00K | 180.00K | |||
| Operating Expenses | 25.47M | 28.26M | 36.76M | 32.09M | 28.42M | |||
| Research and Development | 11.30M | 13.32M | 18.43M | 13.73M | 14.57M | |||
| Selling, General, and Administrative Expenses | 12.88M | 13.64M | 16.92M | 17.17M | 12.75M | |||
| Operating Income | -24.16M | -27.02M | -35.99M | -31.78M | -28.33M | |||
| Interest Income/Expense | -358.30K | -330.40K | -128.30K | -50.00K | -150.00K | |||
| Other Income/Expense | 292.70K | 132.10K | 454.80K | 1.23M | 1.52M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | -24.26M | -27.26M | -35.68M | -30.60M | -26.99M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -24.02M | -26.97M | -35.32M | -30.27M | -26.81M | |||
| EBITDA | -23.06M | -25.91M | -34.84M | -30.84M | -27.38M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.27 | -0.31 | -0.50 | -0.55 | -0.51 | |||
| Non GAAP EPS | -0.27 | -0.31 | -0.51 | -0.55 | -0.50 | |||
| Statistics | ||||||||
| Profit Margin | -1836.16% | -2186.28% | -4555.54% | -9764.52% | -29788.89% | |||
| Operating Profit Margin | -1846.69% | -2190.92% | -4641.78% | -10251.61% | -31477.78% | |||
All data in USD